Lunit

328130.KQ

46.12 USD

0.10

+0.22%

Overview

Last close

46.12 usd

Market cap

1.33B usd

52 week high

90.42 usd

52 week low

23.39 usd

Target price

40.46 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

73.3087

Price/Book Value

8.2153

Enterprise Value

1.33B usd

EV/Revenue

48.1033

EV/EBITDA

-45.3273

Key financials

Revenue TTM

18.16M usd

Gross Profit TTM

4.63M usd

EBITDA TTM

-40.21M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

328.65M usd

Net debt

N/A usd

About

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.